GERMANTOWN, Md., Nov. 4 /PRNewswire-FirstCall/ -- Avalon Pharmaceuticals, Inc. (Nasdaq and ArcaEx(R): AVRX) today announced that Kenneth C. Carter, Ph.D., President & CEO is scheduled to present at the Rodman and Renshaw 7th Annual Healthcare Conference at the New York Palace Hotel in New York on Monday, November 7th at 4:15 pm EST. Dr. Carter will provide an update on the company in the Holmes 2 conference room.
About Avalon Pharmaceuticals, Inc.
Avalon Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Avalon seeks to discover and develop novel therapeutics through the use of a comprehensive, innovative and proprietary suite of technologies based upon large-scale gene expression analysis which it calls AvalonRx(R). Avalon Pharmaceuticals was established in 1999 and is headquartered in Germantown, Maryland.
Avalon Pharmaceuticals, Inc. Noonan Russo Gary Lessing Wendy Lau Chief Financial Officer Tel: (212) 845-4272 Tel: (301) 556-9900 Email: Wendy.Lau1@eurorscg.com Fax: (301) 556-9910 Email: info@avalonrx.com
Avalon Pharmaceuticals, Inc.
CONTACT: Gary Lessing, Chief Financial Officer of Avalon Pharmaceuticals,Inc., +1-301-556-9900, Fax: +1-301-556-9910, info@avalonrx.com; or WendyLau of Noonan Russo, +1-212-845-4272, Wendy.Lau1@eurorscg.com, for Avalon
